To accelerate the transition of novel drugs into clinical trials, Cliantha Research (Toronto, Canada) offers a high-quality bioanalytical veterinary program designed to address regulatory requirements and streamline IND submissions. Our regulated preclinical bioanalytical services support toxicology activities for small-molecule drugs in full alignment with global Good Laboratory Practice (GLP) standards.
Since 2014, our bioanalytical laboratory has delivered customized assay development and validation for both branded and generic veterinary pharmaceuticals. With seasoned scientific leadership and proven expertise, we ensure successful outcomes across every project.
GLP and Non-GLP Non-Clinical Animal Studies
- Fit-To-Purpose Method Development: 10 days and Fit-To-Purpose Pilot Study Sample Analysis: 5 days
- Client Query Management: Within 24 hours
- Biological Species: dogs, cats, horses, rats, etc.,
GLP (Animal) Bioanalytical Studies
- >25 validations in compliance with FDA and OECD GLPs
- MV Reports approved by FDA CVM
| Biological Species | Matrix | Compound |
|---|---|---|
|
Dog
|
Plasma |
Carprofen
Marbofloxacin
Praziquantel
Ivermectin
Cyclosporine
Milbemycin
Enrofloxacin
Cefpodoxime
Deracoxib
Maropitant
Grapiprant
Trilostane
|
|
Cat
|
Plasma |
Cefpodoxime
Deracoxib
Meloxicam
Pimobendan
Cyclosporine
Praziquantel
Amoxicillin/Clavulanate
Milbemycin Oxime
Furosemide
Firocoxib
|
|
Horse
|
Plasma |
Omeprazole
|
|
Dog
|
Serum |
Levothyroxine
|
